logo

Vertex Pharmaceuticals Inc. (VRTX)



Trade VRTX now with
  Date
  Headline
11/16/2018 8:01:55 AM Vertex Receives European CHMP Positive Opinion For ORKAMBI
11/1/2018 4:01:50 AM Vertex Pharma Says EU Grants Marketing Authorization For SYMKEVI In Combination Regimen With Ivacaftor
10/24/2018 4:03:11 PM Vertex Pharma Q3 EPS $0.50 Vs. Loss $0.41 Year Ago
10/19/2018 7:57:20 AM Vertex Receives European CHMP Positive Opinion For KALYDECO
10/1/2018 8:04:31 AM Vertex Announces Access Contract In Denmark For Current And Future Cystic Fibrosis Medicines
9/6/2018 8:04:47 AM Vertex Closes Enrollment Of Two Phase 3 Studies Of VX-659 In Triple Combination With Tezacaftor And Ivacaftor
9/3/2018 3:09:46 AM Vertex Pharma Announces Reimbursement Agreement In Australia For ORKAMBI
8/30/2018 2:00:37 AM Vertex, Genomics Form Collaboration To Use Human Genetics And Data Science To Advance Discovery Of Precision Medicines
8/23/2018 3:01:04 AM Vertex Appoints Ludovic Fenaux As SVP, International Commercial Operations
8/20/2018 3:01:42 AM Vertex Receives PBAC Recommendation For ORKAMBI To Be Listed On Pharmaceutical Benefits Scheme In Australia
8/7/2018 3:55:58 PM Vertex: FDA Approves ORKAMBI As First Medicine To Treat Underlying Cause Of Cystic Fibrosis For Children 2-5 Years